138 related articles for article (PubMed ID: 37755878)
21. Liver transplant-associated graft-versus-host disease.
Smith DM; Agura E; Netto G; Collins R; Levy M; Goldstein R; Christensen L; Baker J; Altrabulsi B; Osowski L; McCormack J; Fichtel L; Dawson DB; Domiati-Saad R; Stone M; Klintmalm G
Transplantation; 2003 Jan; 75(1):118-26. PubMed ID: 12544883
[TBL] [Abstract][Full Text] [Related]
22. Incidence and Risk Factors for Fatal Graft-versus-host Disease After Liver Transplantation.
Kitajima T; Henry M; Ivanics T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Nagai S; Moonka D
Transplantation; 2021 Dec; 105(12):2571-2578. PubMed ID: 33449608
[TBL] [Abstract][Full Text] [Related]
23. Graft versus host disease after liver transplantation: a case report.
Gao PJ; Leng XS; Wang D; Li GM; Huang L; Gao J; Zhu JY
Front Med China; 2010 Dec; 4(4):469-72. PubMed ID: 21125347
[TBL] [Abstract][Full Text] [Related]
24. Graft-versus-host disease after pediatric liver transplantation: A diagnostic challenge.
Attas RAA; Bader RM; Mashhour M; AlQahtani ZA; Mohammed A; Qahtani M; Arain ZB; Faraidy N; Awaji M; Mohammed G; Alharbi HA; AlZahrani M; Aqool A; Salim G
Pediatr Transplant; 2022 May; 26(3):e14205. PubMed ID: 34931754
[TBL] [Abstract][Full Text] [Related]
25. Graft-versus-host disease following living donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Hiroshige S; Gondo H; Takami A; Yasue S; Maehara Y
Liver Transpl; 2004 Mar; 10(3):460-4. PubMed ID: 15004778
[TBL] [Abstract][Full Text] [Related]
26. Late onset of severe graft-versus-host disease following liver transplantation.
Sun B; Zhao C; Xia Y; Li G; Cheng F; Li J; Zhang F; Wang X
Transpl Immunol; 2006 Nov; 16(3-4):250-3. PubMed ID: 17138062
[TBL] [Abstract][Full Text] [Related]
27. Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.
Theurich S; Fischmann H; Shimabukuro-Vornhagen A; Chemnitz JM; Holtick U; Scheid C; Skoetz N; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2012 Sep; (9):CD009159. PubMed ID: 22972135
[TBL] [Abstract][Full Text] [Related]
28. Early Use of Etanercept for Graft-Versus-Host Disease After Liver Transplant: the Importance of Broad Spectrum Infective Prophylaxis.
Boscolo A; Menin E; Zelaschi B; Albertoni L; Zanus G; Baratto F
Exp Clin Transplant; 2020 Feb; 18(1):123-127. PubMed ID: 29619911
[TBL] [Abstract][Full Text] [Related]
29. Treatment of graft-versus-host disease with mesenchymal cells as a complication of a liver transplantation.
Mora L; Alegre F; Rifón JJ; Martí P; Herrero JI
Rev Esp Enferm Dig; 2018 Nov; 110(11):734-736. PubMed ID: 30284904
[TBL] [Abstract][Full Text] [Related]
30. Graft-versus-host disease after orthotopic liver transplantation: multivariate analysis of risk factors.
Elfeki MA; Pungpapong S; Genco PV; Nakhleh RE; Nguyen JH; Harnois DM
Clin Transplant; 2015 Dec; 29(12):1063-6. PubMed ID: 26358521
[TBL] [Abstract][Full Text] [Related]
31. Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.
Rodríguez-Perálvarez M; Guerrero-Misas M; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011639. PubMed ID: 28362060
[TBL] [Abstract][Full Text] [Related]
32. Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant.
Ruggeri A; Sun Y; Labopin M; Bacigalupo A; Lorentino F; Arcese W; Santarone S; Gülbas Z; Blaise D; Messina G; Ghavamzadeh A; Malard F; Bruno B; Diez-Martin JL; Koc Y; Ciceri F; Mohty M; Nagler A
Haematologica; 2017 Feb; 102(2):401-410. PubMed ID: 27758821
[TBL] [Abstract][Full Text] [Related]
33. Graft-versus-host disease after liver transplantation: successful treatment of a case.
Lu Y; Wu LQ; Zhang BY; Cao JY
Transplant Proc; 2008 Dec; 40(10):3784-6. PubMed ID: 19100490
[TBL] [Abstract][Full Text] [Related]
34. Graft versus host disease as a complication after liver transplantation: A rare but serious association.
Pérez-Saborido B; Asensio-Díaz E; Barrera-Rebollo A; Rodríguez-López M; Gonzalo-Martín M; Madrigal-Rubiales B; García-Pajares F; Pacheco-Sánchez D
Rev Esp Enferm Dig; 2016 Jan; 108(1):49-50. PubMed ID: 26765238
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
[TBL] [Abstract][Full Text] [Related]
36. Abatacept use in graft-versus-host disease after orthotopic liver transplantation: a case report.
Elfeki MA; Genco PV; Pungpapong S; Nakhleh RE; Nguyen JH; Harnois DM
Transplant Proc; 2014 Sep; 46(7):2422-5. PubMed ID: 25242798
[TBL] [Abstract][Full Text] [Related]
37. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R;
Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417
[TBL] [Abstract][Full Text] [Related]
38. Acute graft-versus-host disease in pancreas transplantation: a comparison of two case presentations and a review of the literature.
Weinstein A; Dexter D; KuKuruga DL; Philosophe B; Hess J; Klassen D
Transplantation; 2006 Jul; 82(1):127-31. PubMed ID: 16861952
[TBL] [Abstract][Full Text] [Related]
39. FISH diagnosis of acute graft-versus-host disease following living-related liver transplant.
Kanehira K; Riegert-Johnson DL; Chen D; Gibson LE; Grinnell SD; Velgaleti GV
J Mol Diagn; 2009 Jul; 11(4):355-8. PubMed ID: 19460938
[TBL] [Abstract][Full Text] [Related]
40. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Peinemann F; Bartel C; Grouven U
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
